Onconetix, Inc.

NasdaqCM:ONCO Stock Report

Market Cap: US$2.2m

Onconetix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCO?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,0200.77%
Public Companies6,7421.29%
Private Companies6,8461.31%
Individual Insiders15,6853.01%
VC/PE Firms31,7176.08%
General Public456,85387.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 7848%.

Top Shareholders

Top 25 shareholders own 12.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.08%
Altos Venture AG
31,717US$132.9k0%no data
1.52%
Ralph Schiess
7,922US$33.2k0%no data
1.38%
Christian Bruhlmann
7,193US$30.1k40.9%no data
1.31%
Scablis AG
6,846US$28.7k0%no data
1.29%
New Horizon Health Limited
6,742US$28.2k0%no data
0.32%
Hudson River Trading LLC, Asset Management Arm
1,687US$7.1k0%no data
0.15%
Geode Capital Management, LLC
795US$3.3k22.1%no data
0.081%
American Money Management Corporation
423US$1.8k-0.24%no data
0.067%
Scientech Research LLC
351US$1.5k0%no data
0.067%
Bruce Harmon
348US$1.5k0%no data
0.049%
Virtu Financial LLC, Asset Management Arm
254US$1.1k0%no data
0.034%
ZKB Asset Management
176US$737.5-92.8%no data
0.025%
XTX Holdings Limited, Asset Management Arm
131US$548.80%no data
0.017%
Tower Research Capital Europe Limited
87US$364.511.5%no data
0.012%
UBS Asset Management AG
64US$268.1-37.3%no data
0.0079%
James Sapirstein
41US$171.90%no data
0.0079%
Simon Tarsh
41US$171.90%no data
0.0079%
Timothy Ramdeen
41US$171.90%no data
0.0077%
Ajit Singh
40US$167.50%no data
0.0075%
Thomas Meier
39US$163.30%no data
0.0054%
ClearArc Capital, Inc.
28US$117.40%no data
0.004%
The Vanguard Group, Inc.
21US$87.90%no data
0.0038%
Andrew Oakley
20US$83.70%no data
0.00019%
Bank of America Corporation, Asset Management Arm
1US$4.20%no data
0.00019%
Morgan Stanley, Investment Banking and Brokerage Investments
1US$4.20%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/22 01:10
End of Day Share Price 2025/06/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Onconetix, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vernon BernardinoH.C. Wainwright & Co.
Jason McCarthyMaxim Group